- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03665818
The Influence of Mandibular Advancement Device Treating OSAHS on Primary Prevention of Ischemic Stroke
- The purpose of this study is to detect the differences of carotid atherosclerosis severity between patients with or without OSAHS(Obstructive Sleep Apnea and Hypopnea Syndrome) in a cross-sectional study in a large sample.
- Then a longitudinal control study is conducted to observe the progress of the carotid atherosclerosis by vascular ultrasonography and the occurrence of cerebrovascular events after the intervention of the oral appliance for treating OSAHS,and finally explore the feasibility of using oral appliance to treat OSAHS in primary prevention of ischemic stroke.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
- the relevance of OSAHS and carotid atherosclerosis Patients are distributed questionnaire and recruited from neurology clinic,vascular ultrasonography clinic of Xuanwu Hospital if they match the inclusion criteria. After initial screening, carotid atherosclerosis patients with skeptical OSAHS are sent to sleep center for polysomnography examination to determine the severity of OSAHS. At least 50 patients for mild, moderate, severe OSAHS each are recruited for OSAHS Group. At least 100 patients without snoring from questionnaire and without OSAHS after PSG screening are recruited for non OSAHS Group. Vascular ultrasonography examination for carotid are done for the two groups. Data of carotid vascular plaque from two groups are collected. Statistics are done to detect differences of carotid atherosclerosis severity between patients with and without OSAHS, also the severity of OSAHS.
- the relevance of the progress of carotid atherosclerosis and oral appliances intervention for treating OSAHS All carotid atherosclerosis patients with OSAHS are from patients of the first study. If they consent the treatment of oral appliances, they are recruited into this second study. At least 100 patients are recruited. They are divided into 2 groups by randomized block design by Evidence-based Medicine Center of Xuanwu Hospital. One group is oral appliance intervention group, the other group is no intervention group. The intervention group patients accept oral appliance treatment, and no intervention group patients do not accept OSAHS treatment. The two groups both accept anti-hypertension treatment or anti-diabetes treatment, or anti-hyperlipidemia treatment according to their own situation in neurology clinic.
At timepoint of initial time, one month after oral appliance treatment, one and a half year after oral appliance treatment, the intervention group should accept PSG(Polysomnography) examination to monitor the treatment of OSAHS.
At timepoint of initial time, one month after oral appliance treatment, one and a half year after oral appliance treatment, the two groups should accept breath holding test to monitor the cerebral vascular reserve.
At timepoint of initial time, one and a half year after oral appliance treatment, the two groups should accept carotid vascular ultrasonography examination to monitor the progress of carotid atherosclerosis.
Cerebrovascular events and death are recorded from initial time. Statistics are done to detect the influence of treatment of OSAHS on carotid atherosclerosis.
Studietyp
Inskrivning (Förväntat)
Fas
- Inte tillämpbar
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Barn
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- diagnosed with atherosclerosis by vascular ultrasonography
- diagnosed with OSAHS by polysomnography
Exclusion Criteria:
- patients who have stroke already
- patients who can not wear oral appliances according to experiment requirements
- patients who have bad periodontal condition or teeth number less than 20
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Oral appliance intervention
|
mandibular advancement device to enlarge pharyngeal airway space to get rid of apnea and hypopnea events
|
Inget ingripande: Without oral appliance intervention
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
apnea hypopnea events 0 in Times
Tidsram: initial time when patients are recruited
|
apnea and hypopnea times per hour
|
initial time when patients are recruited
|
apnea hypopnea events 1 in Times
Tidsram: one month after oral appliance treatment
|
apnea and hypopnea times per hour
|
one month after oral appliance treatment
|
apnea hypopnea events 2 in Times
Tidsram: one and a half years after oral appliance treatment
|
apnea and hypopnea times per hour
|
one and a half years after oral appliance treatment
|
longest apnea time 0 in Seconds
Tidsram: initial time when patients are recruited
|
longest apnea or hypopnea time
|
initial time when patients are recruited
|
longest apnea time 1 in Seconds
Tidsram: one month after oral appliance treatment
|
longest apnea or hypopnea time
|
one month after oral appliance treatment
|
longest apnea time 2 in Seconds
Tidsram: one and a half years after oral appliance treatment
|
longest apnea or hypopnea time
|
one and a half years after oral appliance treatment
|
Blood oxygen saturation less than 90% of the total monitoring time percentage 0 in percentage
Tidsram: initial time when patients are recruited
|
Blood oxygen saturation less than 90% of the total monitoring time percentage
|
initial time when patients are recruited
|
Blood oxygen saturation less than 90% of the total monitoring time percentage 1 in percentage
Tidsram: one month after oral appliance treatment
|
Blood oxygen saturation less than 90% of the total monitoring time percentage
|
one month after oral appliance treatment
|
Blood oxygen saturation less than 90% of the total monitoring time percentage 2 in percentage
Tidsram: one and a half years after oral appliance treatment
|
Blood oxygen saturation less than 90% of the total monitoring time percentage
|
one and a half years after oral appliance treatment
|
lowest Oxygen Saturation 0 in percentage
Tidsram: initial time when patients are recruited
|
blood lowest oxygen saturation during the whole night
|
initial time when patients are recruited
|
lowest Oxygen Saturation 1 in percentage
Tidsram: one month after oral appliance treatment
|
blood lowest oxygen saturation during the whole night
|
one month after oral appliance treatment
|
lowest Oxygen Saturation 2 in percentage
Tidsram: one and a half years after oral appliance treatment
|
blood lowest oxygen saturation during the whole night
|
one and a half years after oral appliance treatment
|
atherosclerosis plaque thickness 0 in common carotid artery in milimetre
Tidsram: initial time when patients are recruited
|
atherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
|
initial time when patients are recruited
|
atherosclerosis plaque thickness 1 in common carotid artery in milimetre
Tidsram: one and a half years after oral appliance treatment
|
atherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
|
one and a half years after oral appliance treatment
|
atherosclerosis plaque length 0 in common carotid artery in milimetre
Tidsram: initial time when patients are recruited
|
atherosclerosis plaque length is distance from the beginning to the end of a separate plaque
|
initial time when patients are recruited
|
atherosclerosis plaque length 1 in common carotid artery in milimetre
Tidsram: one and a half years after oral appliance treatment
|
atherosclerosis plaque length is distance from the beginning to the end of a separate plaqu
|
one and a half years after oral appliance treatment
|
atherosclerosis plaque thickness 0 in internal carotid artery in milimetre
Tidsram: initial time when patients are recruited
|
atherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
|
initial time when patients are recruited
|
atherosclerosis plaque thickness 1 in internal carotid artery in milimetre
Tidsram: one and a half years after oral appliance treatment
|
atherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
|
one and a half years after oral appliance treatment
|
atherosclerosis plaque thickness 0 in carotid bulb in milimetre
Tidsram: initial time when patients are recruited
|
atherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
|
initial time when patients are recruited
|
atherosclerosis plaque thickness 1 in carotid bulb in milimetre
Tidsram: one and a half years after oral appliance treatment
|
atherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
|
one and a half years after oral appliance treatment
|
atherosclerosis plaque length 0 in internal carotid artery in milimetre
Tidsram: initial time when patients are recruited
|
atherosclerosis plaque length is distance from the beginning to the end of a separate plaque
|
initial time when patients are recruited
|
atherosclerosis plaque length 1 in internal carotid artery in milimetre
Tidsram: one and a half years after oral appliance treatment
|
atherosclerosis plaque length is distance from the beginning to the end of a separate plaque
|
one and a half years after oral appliance treatment
|
atherosclerosis plaque length 0 in carotid bolb in milimetre
Tidsram: initial time when patients are recruited
|
atherosclerosis plaque length is distance from the beginning to the end of a separate plaque
|
initial time when patients are recruited
|
atherosclerosis plaque length 1 in carotid bolb in milimetre
Tidsram: one and a half years after oral appliance treatment
|
atherosclerosis plaque length is distance from the beginning to the end of a separate plaque
|
one and a half years after oral appliance treatment
|
breath holding index 0 in percentage/seconds
Tidsram: initial time when patients are recruited
|
breath holding index = (v2-v1)/v2*100/t.
v2 is average velocity of middle cerebral artery after breath holding, v1 is average velocity of middle cerebral artery before breath holding, t is time for breath holding.
|
initial time when patients are recruited
|
breath holding index 0 in percentage/seconds
Tidsram: one and a half years after oral appliance treatment
|
breath holding index = (v2-v1)/v2*100/t.
v2 is average velocity of middle cerebral artery after breath holding, v1 is average velocity of middle cerebral artery before breath holding, t is time for breath holding.
|
one and a half years after oral appliance treatment
|
End systolic velocity of common carotid artery 0 in cm/s
Tidsram: initial time when patients are recruited
|
the velocity of common carotid artery at the end of systolic period
|
initial time when patients are recruited
|
End systolic velocity of common carotid artery 1 in cm/s
Tidsram: one and a half years after oral appliance treatment
|
the velocity of common carotid artery at the end of systolic period
|
one and a half years after oral appliance treatment
|
End systolic velocity of internal carotid artery 0 in cm/s
Tidsram: initial time when patients are recruited
|
the velocity of internal carotid artery at the end of systolic period
|
initial time when patients are recruited
|
End systolic velocity of internal carotid artery 1 in cm/s
Tidsram: one and a half years after oral appliance treatment
|
the velocity of internal carotid artery at the end of systolic period
|
one and a half years after oral appliance treatment
|
End systolic velocity of carotid bulb 0 in cm/s
Tidsram: initial time when patients are recruited
|
the velocity of carotid bulb at the end of systolic period
|
initial time when patients are recruited
|
End systolic velocity of carotid bulb 1 in cm/s
Tidsram: one and a half years after oral appliance treatment
|
the velocity of carotid bulb at the end of systolic period
|
one and a half years after oral appliance treatment
|
end diastolic velocity of common carotid artery 0 in cm/s
Tidsram: initial time when patients are recruited
|
the velocity of common carotid artery at the end of diastolic period
|
initial time when patients are recruited
|
end diastolic velocity of common carotid artery 1 in cm/s
Tidsram: one and a half years after oral appliance treatment
|
the velocity of common carotid artery at the end of diastolic period
|
one and a half years after oral appliance treatment
|
end diastolic velocity of internal carotid artery 0 in cm/s
Tidsram: initial time when patients are recruited
|
the velocity of internal carotid artery at the end of diastolic period
|
initial time when patients are recruited
|
end diastolic velocity of internal carotid artery 1 in cm/s
Tidsram: one and a half years after oral appliance treatment
|
the velocity of internal carotid artery at the end of diastolic period
|
one and a half years after oral appliance treatment
|
end diastolic velocity of carotid bulb 0 in cm/s
Tidsram: initial time when patients are recruited
|
the velocity of carotid bulb at the end of diastolic period
|
initial time when patients are recruited
|
end diastolic velocity of carotid bulb 1 in cm/s
Tidsram: one and a half years after oral appliance treatment
|
the velocity of carotid bulb at the end of diastolic period
|
one and a half years after oral appliance treatment
|
Samarbetspartners och utredare
Sponsor
Publikationer och användbara länkar
Allmänna publikationer
- Qin L, Li N, Tong J, Hao Z, Wang L, Zhao Y. Impact of mandibular advancement device therapy on cerebrovascular reactivity in patients with carotid atherosclerosis combined with OSAHS. Sleep Breath. 2021 Sep;25(3):1543-1552. doi: 10.1007/s11325-020-02230-x. Epub 2021 Jan 7.
- Hao Z, Qin L, Tong J, Li N, Zhai Y, Zhao Y. The differences of carotid atherosclerosis among non-OSAHS and OSAHS patients of different severities: a cross-sectional study. Sleep Breath. 2021 Jun;25(2):639-648. doi: 10.1007/s11325-020-02145-7. Epub 2020 Jul 27.
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Hjärt-kärlsjukdomar
- Kärlsjukdomar
- Cerebrovaskulära störningar
- Hjärnsjukdomar
- Sjukdomar i centrala nervsystemet
- Sjukdomar i nervsystemet
- Luftvägssjukdomar
- Arterioskleros
- Arteriella ocklusiva sjukdomar
- Apné
- Andningsstörningar
- Sömnstörningar, inneboende
- Dyssomni
- Vakna sömnstörningar
- Stroke
- Sömnapnésyndrom
- Ischemisk stroke
- Åderförkalkning
Andra studie-ID-nummer
- CSA-Z2015-06
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Sömnapnésyndrom
-
University of Wisconsin, MadisonPhilips HealthcareAvslutadSömn, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization
-
National University of SingaporeRekryteringReduktion av skärmanvändning + Sleep Extension | FrilevandeSingapore
-
Brigham and Women's HospitalAktiv, inte rekryterandeSömnstörningar, inneboende | Sömnstörningar, dygnsrytm | Advanced Sleep Phase Syndrome (ASPS) | Fördröjd sömnfassyndrom | Shift-Work Sömnstörning | Försenad sömnfas | Icke-24 timmars sömn-vaken störning | Advanced Sleep Phase Syndrome | Avancerad sömnfas | Oregelbundet sömn-vakna syndrom | Skift Arbetstyp Dygnsrytm...Förenta staterna
-
Brigham and Women's HospitalCharite University, Berlin, Germany; Stanford UniversityRekryteringSömnstörningar, inneboende | Vakna sömnstörningar | Sömnstörningar, dygnsrytm | Advanced Sleep Phase Syndrome (ASPS) | Fördröjd sömnfassyndrom | Shift-Work Sömnstörning | Försenad sömnfas | Icke-24 timmars sömn-vaken störning | Advanced Sleep Phase Syndrome | Avancerad sömnfas | Oregelbundet sömn-vakna syndrom | Skift Arbetstyp Dygnsrytm Sömnstörning och andra villkorFörenta staterna
-
Maastricht University Medical CenterEpilepsiecentrum KempenhaegheAvslutadRolandsk epilepsi | Landau-Kleffners syndrom | Nattlig frontallobsepilepsi | Elektrisk status Epilepticus under Slow Wave SleepNederländerna
-
Tyco Healthcare GroupOkänd
-
Northwell HealthJazz PharmaceuticalsRekryteringElektrisk status Epilepticus of Slow-Wave SleepFörenta staterna
-
Eisai Inc.AvslutadOregelbunden Sleep Wake Rhythm DisorderFörenta staterna
-
Brigham and Women's HospitalStanford UniversityRekryteringVakna sömnstörningar | Sömnstörning | Sömnstörningar, dygnsrytm | Dygnsrytmstörningar | Circadian Rhythm Sömnstörning | Advanced Sleep Phase Syndrome (ASPS) | Fördröjd sömnfassyndromFörenta staterna
Kliniska prövningar på oral appliance treatment
-
Viveve Inc.AvslutadVaginal slapphet efter förlossning | Sexuell funktion efter förlossningKanada, Italien, Japan, Spanien
-
Ospedale Generale Di Zona Moriggia-PelasciniAvslutadParkinsons sjukdom och Pisa syndromItalien
-
Universitätsklinikum Hamburg-EppendorfAvslutad
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)RekryteringAutismspektrumstörning | AutismFörenta staterna
-
Reistone Biopharma Company LimitedAvslutad
-
Stanford UniversityRekryteringAutismspektrumstörningFörenta staterna
-
Virginia Polytechnic Institute and State UniversityAvslutadAutismspektrumstörningFörenta staterna
-
Universidad Católica San Antonio de MurciaAvslutadRyggont | Atletiska skador | Ryggbelastning Nedre ryggenSpanien
-
InnoVeinRekryteringKronisk venös insufficiensAustralien
-
University of BarcelonaITA salud mentalAktiv, inte rekryterandeAnorexia nervosa | Bulimia nervosa | Hetsätning | Ätstörningar | Ätstörningar i tonåren | Ät- och ätstörningarSpanien